Although we talk about Cancer as one disease, we now know that all cancers are different. Even within the same type of Primary Bone Cancer, one person’s bone cancer may be very different to another’s. This means that treatment for one group of patients won’t necessarily work for another. One of the main drawbacks in cancer research has been the lack of laboratory tools that represent the true complex nature of tumours in patients. This has impacted our understanding of cancer biology and drug development, and unfortunately, sometimes resulted in findings in the lab that aren’t always reproduced in the clinic.

We need efficient models that can represent and behave very similarly to each patient’s original tumour, that will allow researchers to predict which current and future therapies would work best for each patient.

To develop a methodology through which it will be possible to study osteosarcoma within its natural environment, Professors Sibylle Mittnacht and Wenhui Song, from University College London, with PhD student Luke Farrow, have teamed up to combine their skills and experience in tissue engineering and cancer research.

What were the aims of this research project?

The PhD research project aimed to make use of front line innovative tissue engineering technology to propagate human osteosarcoma cancers within their natural setting, yet outside a patient’s body. The goal was to generate a realistic and reliable tool for drug testing and to increase the speed and means of searching for new and more effective medicines.

A further partner was Dr Sandra Strauss, a clinical oncologist who treats patients with osteosarcoma; she provided her expertise on how these tumours mirror those inside the body. This way of collaborating allows potential treatments to be tested and determine their effectiveness before they are given to the patient.

A second aim was to use the technology to study how osteosarcoma cancers begin and what causes them.

Although the overarching goal of this project is to generate a realistic model for the study of osteosarcoma. it could be extended to other forms of primary bone cancer, as search continues for new and more effective medicines.

Results of the study

This PhD project developed a 3D, bone-mimicking habitat in a dish, exploiting natural bone cells to build the hard, calcium-containing bone material around a 3D, gelatin-based scaffold. This supported the growth of osteosarcoma cells and normal non-cancerous bone cells, including stem cells and bone-forming cells. The different cells were dyed different colours, which allowed cancer cells to be assessed in real-time alongside normal bone cells, as they grew in this 3D habitat. This allowed the behaviour of the cancer to be studied in the context of its natural environment as well as the specific roles of the non-cancerous neighbour cells it exploits to grow and evade treatments. The model was designed to be easy and cheap to use, without the need for specialist equipment, allowing its use in any biology lab regardless of resources. The model’s modular design allows researchers to add and remove different elements of the bone as they wish, to study how these individual components of the bone, or combinations thereof, might affect tumour development.

Using this model, the researchers observed that tumour growth was significantly altered compared to 2D cultures or scaffolds without bone cells, which highlighted the key role that the bone environment plays in osteosarcoma behaviour and development. Further studies are still underway to better understand the exact mechanisms of this altered behaviour, to hopefully understand the key role that the bone habitat plays in the development of osteosarcoma.

How could this project improve treatment options for osteosarcoma patients?

The tool developed during this PhD project offers a more accurate, customisable platform for researchers to study osteosarcoma and test different treatments. Studying osteosarcoma in this way may open the door to better therapies for osteosarcoma and reduce the amount of resources wasted on ineffective drugs developed using inaccurate laboratory models.

The Bone Cancer Research Trust would like to thank the Clive and Sylvia Richards Charity for helping to make this project a reality.

Sponsor Our Research Into Osteosarcoma